RETRACTION: Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer (Retraction of Vol 183, Pg 78, 2024)Courtney J. Riedinger,David A. Barrington,Christa I. Nagel,Wafa K. Khadraoui,Paulina J. Haight,Crystal Tubbs,Floor J. Backes,David E. Cohn,David M. O'Malley,Larry J. Copeland,Laura M. ChambersGYNECOLOGIC ONCOLOGY（2024）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
